Mirae Asset Global ETFs Holdings
FATE icon

Mirae Asset Global ETFs Holdings’s Fate Therapeutics FATE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.3K Buy
53,619
+1,246
+2% +$1.52K ﹤0.01% 2845
2025
Q4 		$51.5K Buy
52,373
+1,701
+3% +$2.04K ﹤0.01% 2927
2025
Q3 		$63.8K Sell
50,672
-6,649
-12% -$7.17K ﹤0.01% 2865
2025
Q2 		$64.2K Sell
57,321
-2,540
-4% -$2.95K ﹤0.01% 2814
2025
Q1 		$47.3K Buy
59,861
+2,580
+5% +$3.16K ﹤0.01% 2861
2024
Q4 		$94.5K Sell
57,281
-5,983
-9% -$15.1K ﹤0.01% 2725
2024
Q3 		$222K Buy
63,264
+11,520
+22% +$44.8K ﹤0.01% 2329
2024
Q2 		$170K Buy
+51,744
New +$227K ﹤0.01% 2338

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return